Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
209.50    -3.50 (-1.64%)
Bid:
207.00
Ask:
212.00
Spread: 5.00 (2.415%)
Market Cap: £142.99m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Quarterly Syndicate Mid Point Forecasts

4 Apr 2023 07:00

RNS Number : 2139V
Helios Underwriting Plc
04 April 2023
 

4th April 2023

 

Helios Underwriting plc

('Helios' or 'the Company')

 

Quarterly Syndicate Mid Point Forecasts

 

Helios, the unique investment vehicle which acquires and consolidates private underwriting capacity at Lloyd's, announces the current mid-point forecasts in respect of its portfolio of syndicate capacity for the 2020 and 2021 years of account based on 4th quarter 2022 estimates.

 

Martin Reith, Chief Executive, commented:

 

"Helios' unique proposition, as the only listed consolidator of private capital at Lloyd's, is well positioned to benefit from the Lloyd's market's recently announced mid point forecasts. Helios has built and curated an outstanding portfolio of the better performing syndicates and, as a consequence of underwriting discipline and judicious capital deployment, we are delighted to see improved underwriting profitability in the Lloyd's market. We expect Helios' portfolio to continue to outperform the market as we have since 2013 for closed years of accounts.

 

Recognising stronger market conditions, we increased our retained capacity to £238m for the 2023 year of account, an increase of 34%. We remain confident that we shall deliver improved results and superior return on equity underpinned by our favourable Economic Capital Assessment (ECA), and look forward to creating further shareholder value as the benefits of the larger retained capacity flows to the income statement."

 

Year of Account

 

 

2020

2021

2022

2023

 

 

£m

£m

£m

£m

 

Capacity - Position as at 30th September 2022

 

Retained

66.5

93.5

171.9

 

Reinsured

49.1

51.5

60.8

 

115.6

145.0

232.7

 

Capacity Acquired since 30th September 2022

 

 

Retained

5.6

5.8

5.7

 

Reinsured

0.0

0.0

0.0

 

5.6

5.8

5.7

 

Total capacity as at 31st March 2023

 

Retained

72.0

99.3

177.6

238.4

 

Reinsured

49.1

51.5

60.8

58.3

 

121.2

150.8

238.4

296.7

 

Mid-point forecast at 30th September 2022

1.94%

2.29%

 

Final result / Current mid-point forecast

3.11%

2.37%

 

Lloyd's Market Average

0.91%

4.20%

 

Helios out performance

2.20%

(1.83)%

 

 

Commentary

 

The 2020 result showed an improvement over the midpoint forecasts as at 30th September 2022. The overall result was impacted by the negative investment returns recognised during the year and the impact from the COVID-19 pandemic.

 

The development of the mid point estimate for 2021 has been held back by losses from Ukraine that were recognised in 2022. The improved returns from the investment portfolio should benefit this year before it closes at the end of this year.

 

The 2022 underwriting year has been impacted by the loss from Hurricane Ian that will create a drag on the earnings recognised in 2022.

 

The outperformance of 2.2% of the portfolio against the average for the Lloyd's market for 2020 continues the trend of closed year of account outperformance achieved since 2013.

 

Notes

1) The table above shows the capacity as at 31st March 2023, splitting the capacity retained by Helios and the capacity that is ceded to quota share reinsurers. 

2) The mid-point forecasts for 2020 and 2021 years of account as of 4th quarter 2022 have been aggregated at syndicate level from estimates supplied by Managing Agents.

3) The impact on Helios will be as follows:

a. The change in the mid point estimates on the retained capacity over the year will be recognised in the Helios income statement in the year to 31st December 2022.

b. The overall change in the result will be recognised by Helios in cash at the close of the year of account.

 

For further information, please contact:

Helios Underwriting plc

 

Helios Underwriting plc

Martin Reith - Chief Executive +44(0)7720 292 505

Nigel Hanbury - Executive Deputy Chairman +44(0)7787 530 404

Arthur Manners - Chief Financial Officer +44(0)7754 965 917

 

Shore Capital

Robert Finlay +44(0)20 77408 4080

David Coaten

Henry Willcocks

 

Buchanan

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £297m of capacity for the 2023 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUGACUPWGAW
Date   Source Headline
27th May 20227:00 amRNSFinal Results
23rd May 20229:10 amRNSQuarterly Syndicate Mid Point Forecasts
8th Apr 20227:00 amRNSPCA Shareholding
1st Apr 20227:00 amRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSSyndicate Mid Point Forecasts and Estimate of NAV
4th Mar 20227:00 amRNSDirector/PDMR Shareholding
25th Feb 20227:37 amEQSHelios Underwriting (HUW): Initiation - Increased Lloyd's participation at the right time
10th Jan 20228:56 amRNSAcquisition
4th Jan 20227:00 amRNSDirector/PDMR Shareholding
4th Jan 20227:00 amRNSTotal Voting Rights
22nd Dec 20217:01 amRNS2022 Helios Retained Capacity
22nd Dec 20217:00 amRNSAcquisition of further Limited Liability Vehicles
20th Dec 20217:00 amRNSAcquisition, Issue of Equity & Total Voting Rights
6th Dec 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20217:00 amRNSAcquisition of further Limited Liability Vehicles
1st Dec 20212:31 pmRNSTotal Voting Rights
26th Nov 20217:00 amRNSQuarterly Syndicate Mid-point Forecasts
22nd Nov 20217:00 amRNSDirector/PDMR Shareholding
17th Nov 20217:00 amRNSAcquisition of Shareholding, Issue of Equity & TVR
15th Nov 202111:27 amRNSCapacity Value Update
15th Nov 20217:00 amRNSDirector/PDMR Shareholding
11th Nov 20217:00 amRNSAcquisition of further Limited Liability Vehicles
8th Nov 20217:00 amRNSDirector/PDMR Shareholding
18th Oct 20217:00 amRNSDirector/PDMR Shareholding
8th Oct 20217:00 amRNSAcquisition of further Limited Liability Vehicles
4th Oct 20217:00 amRNSAcquisition of Further Limited Liability Vehicles
30th Sep 20217:00 amRNSHalf-year Report
23rd Sep 20217:00 amRNSAcquisition of Limited Liability Vehicles
22nd Sep 20217:00 amRNSAcquisition, Issue of Equity & Total Voting Rights
20th Aug 20217:00 amRNSQuarterly Syndicate Mid-point Forecasts
17th Aug 20217:00 amRNSIssue of Equity and Director/PDMR Shareholding
28th Jul 20217:00 amRNSDirector/PCA Shareholding
29th Jun 20211:32 pmRNSResult of AGM
16th Jun 20217:00 amRNSUpdate re AGM
2nd Jun 20217:00 amRNSDirector/PCA Shareholding
1st Jun 20212:21 pmRNSDividend Declaration
28th May 20217:00 amRNSFinal Results for the year ended 31 December 2020
18th May 20212:30 pmEQSHardman & Co Investor Forum research: Helios Underwriting (HUW): Timing its growth with the insurance cycle
14th May 20217:00 amRNSQuarterly Syndicate Mid-point Forecasts
11th May 20217:00 amRNSHolding(s) in Company
27th Apr 202112:57 pmEQSHardman & Co Research : Hardman & Co Video Event | Helios Underwriting Plc - Investor Forum
27th Apr 20217:00 amRNSHolding(s) in Company
21st Apr 20217:00 amRNSDirectorate Changes
20th Apr 202111:35 amRNSHolding(s) in Company
1st Apr 202112:34 pmRNSResult of GM, TVR and Directors' Participation
1st Apr 20217:00 amRNSQuarterly Syndicate Mid-point Forecasts
30th Mar 20217:00 amRNSResult of Open Offer
11th Mar 20217:00 amRNSDirector/PCA Shareholding
9th Mar 20217:00 amRNSResult of Placing and Subscription
8th Mar 20214:45 pmRNSFundraising to raise up to approximately £60m

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.